The parent protein from which BPC-157 was purportedly derived has never been fully disclosed
Modelled patients were assumed to receive once-weekly semaglutide or dulaglutide for 3 years, in line with previously published analyses of GLP-1 receptor agonists and data from general practice in Europe, which reported a mean duration of treatment with GLP-1 receptor agonists of 29.35 months (rounded to 3 years, as treatment switching in the IQVIA CORE Diabetes Model can only occur at the end of an annual cycle) [14, 29,30,31]
Patients sourcing compounds from online retailers, med spas or overseas suppliers have limited incentive to raise the subject with their doctor, and may not perceive what they are taking as a medical concern at all
These products are typically supplied in lyophilized (freeze-dried) powder form , with notable differences between sellers in terms of testing transparency, documentation, and overall quality signals